Bioxyne Limited logo

Bioxyne Limited (BXN)

Market Closed
ASX ASX
38.94M Market Cap
- P/E Ratio
- Div Yield
213,850 Volume
0 Eps
Want to track BXN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BXN is not paying dividends to its shareholders.
The last earnings report, released on Feb 26, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Bioxyne Limited has completed 4 stock splits, with the recent split occurring on Jun 24, 2026.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

Bioxyne Limited (BXN) FAQ

On which exchange is it traded?

Bioxyne Limited is listed on ASX.

What is its stock symbol?

The ticker symbol is BXN.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 38.94M.

Has Bioxyne Limited ever had a stock split?

Bioxyne Limited had 4 splits and the recent split was on Jun 24, 2026.

Bioxyne Limited Profile

Food Products Industry
Consumer Staples Sector
Mr. Samuel Watson CEO
ASX Exchange
Q77474122 CUSIP
Australia Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Bioxyne Limited is a dynamic life sciences and consumer health products company with a global reach, including the United Kingdom, Japan, Europe, and Australia. Established in 1998 and headquartered in Sydney, Australia, the company specializes in the manufacture and distribution of a broad range of consumer health products. These include patented probiotics, health supplements, therapeutic goods, and alternative medicines. Bioxyne Limited is deeply committed to enhancing wellness through its diverse product portfolio, which leverages the power of plant-based components and cutting-edge scientific research. The company's operations also extend to the provision of product research and development services and the innovative use of telemedicine through its BLS Clinics platform.

Products and Services

Bioxyne Limited offers an extensive array of products and services designed to promote health and well-being among consumers worldwide:

  • Consumer Health Products: A broad range of products aimed at improving the daily health and wellness of individuals.
  • Patented Probiotics: Including lactobacillus fermentum VRI-003, these are specially designed for gut health and immune support.
  • Health Supplements: A variety of supplements including vitamins, minerals, and other essential nutrients catering to the diverse health needs of the global population.
  • Therapeutic Goods and Alternative Medicines: Products developed to offer therapeutic benefits and alternative health solutions.
  • Wellness Products and Supplements: This includes plant-based wellness products and supplements such as cannabinoids, cannabis extracts, manuka honey, skin care products, and mushroom complexes.
  • Functional Food Products: The company develops functional food products with health-enhancing ingredients, focusing on innovation in the field of dietary supplements.
  • Product Research and Development Services: Bioxyne Limited is engaged in extensive research and development, aiming to bring forward innovative health products and solutions.
  • Telemedicine Services: Through its BLS Clinics, Bioxyne Limited offers telehealth services, catering to the evolving healthcare needs of its customers.
  • Distribution Channels: The company utilizes a combination of online sales, wholesale, and direct sales strategies to reach its customers in the United States, Asia, and other parts of the world.

Contact Information

Address: 50 Clarence Street
Phone: 61 2 9078 8180